US5505946A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Bowman-birk inhibitor concentrate compositions and methods for the treatment of pre-malignant tissue
Assignee: CS OILSEEDS Inc
•
Filing: 1994-04-01
•
Granted: 1996-04-09
•
Expires: 2014-04-01
Abstract
Abstract A composition containing a Bowman-Birk Inhibitor Concentrate (BBIC) for the treatment of pre-malignant tissue is provided. Methods of using this composition in the prevention of cancer are also provided.
Inventors
- 👤 Ann R. Kennedy
- 👤 Bernard F. Szuhaj
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-11-09 22:32
CPC Classifications
A; A61; A61K; A61K36/00; A61K36/18; A61K36/185; A61K36/48
Claims Analysis
Total Claims: 11
Claim 1
Independent Claim
20 words
A composition for the treatment of cancer comprising a BBI concentrate product having at least 25 C.I. units of activity.
Claim 2
Dependent Claim
20 words
A composition for the treatment of cancer comprising a BBI concentrate product having at least 25 C.I. units of activity.
Claim 3
Dependent Claim
11 words
The composition of claim 1 further comprising a pharmaceutically acceptable carrier.
Claim 4
Independent Claim
29 words
A method for treating pre-malignant tissues in an animal comprising administering a BBI concentrate product having at least 25 C.I. units of activity to an animal having pre-malignant tissue.
Claim 5
Independent Claim
29 words
A method for treating pre-malignant tissues in an animal comprising administering a BBI concentrate product having at least 25 C.I. units of activity to an animal having pre-malignant tissue.
Claim 6
Dependent Claim
19 words
The method of claim 3 wherein the BBI Concentrate product is administered in combination with a pharmaceutically acceptable carrier.
Claim 7
Dependent Claim
21 words
The method of claim 3, wherein the pre-malignant tissue comprises breast, colon, oral mucosa, esophageal, liver, lung, hematopoietic or prostate tissue.
Claim 8
Independent Claim
27 words
A method for preventing or inhibiting cancer in an animal comprising administering to an animal a BBI concentrate product having at least 25 C.I. units of activity.
Claim 9
Independent Claim
27 words
A method for preventing or inhibiting cancer in an animal comprising administering to an animal a BBI concentrate product having at least 25 C.I. units of activity.
Claim 10
Dependent Claim
19 words
The method of claim 6 wherein the BBI Concentrate product is administered in combination with a pharmaceutically acceptable carrier.
Claim 11
Dependent Claim
22 words
The method of claim 7 wherein the cancer being inhibited is breast, colon, oral mucosa, esophageal, liver, lung, hematopoietic or prostate cancer.
References Cited (Backward Citations)
US4793996A
Cited
US5217717A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1999-04-09 | 1999-10-09 | 2000-04-09 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 2003-04-09 | 2003-10-09 | 2004-04-09 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2007-04-09 | 2007-10-09 | 2008-04-09 | $7700.00 | Window Closed / Lapsed |